Cryotherapy_for_cutaneous_Kaposi's_sarcoma_(KS)_associated_with_acquired_immune_deficiency_syndrome_(AIDS):_a_phase_II_trial._To_assess_the_response_and_toxicity_of_liquid_nitrogen_cryotherapy_for_cutaneous_lesions_of_Kaposi's_sarcoma_(KS)_associated_with_AIDS,_we_evaluated_20_subjects_with_biopsy-proven_KS_in_a_phase_II_clinical_trial._Subjects_had_two_to_four_cutaneous_KS_indicator_lesions_treated_with_liquid_nitrogen_cyrotherapy._Treatment_was_repeated_at_3_week_intervals,_allowing_adequate_healing_time._On_average,_subjects_received_three_treatments_per_lesion_with_a_mean_follow-up_time_of_11_weeks_(range_of_6-25_weeks)._One_treatment_consisted_of_two_freeze-thaw_cycles,_with_thaw_times_ranging_from_11_to_60_s_per_cycle._A_complete_response_was_observed_in_80%_of_treated_KS_lesions_and_lasted_a_minimum_of_6_weeks_following_the_completion_of_therapy._Greater_than_50%_cosmetic_improvement_of_KS_was_observed._Histopathology_of_treated_lesions_correlated_poorly_with_cosmetic_improvement._Response_was_not_predicted_by_tolerance_to_zidovudine_therapy,_CD4+_cell_count,_presence_of_B_symptoms,_or_previous_chemotherapy._Subjects_without_prior_history_of_opportunistic_infection_(OI)_were_more_likely_to_have_a_better_response_than_those_with_a_prior_history_of_OI._Subjects_tolerated_cryotherapy_well._Blistering_occurred_frequently,_but_local_pain_was_limited_and_relieved_by_acetaminophen._Secondary_infection_did_not_occur._Based_on_this_study,_we_recommend_cryotherapy_to_subjects_with_cutaneous_KS_lesions._Liquid_nitrogen_cryotherapy_is_easily_applied_as_a_primary_therapy,_and_may_also_have_a_role_in_the_treatment_of_cutaneous_KS_lesions_that_respond_slowly_or_show_incomplete_cosmetic_improvement_with_systemic_therapies.